Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05356221 · ClinicalTrials.gov registry record
Cross-sectional Evaluation of the Subjective Performance and Satisfaction With Ponto Sound Processors
A clinical trial, sponsored by Oticon Medical.
- Completed
- Registry status
- 170
- Enrollment target
NCT05356221 is a clinical trial that has completed, run by Oticon Medical. The registered enrollment target is 170 participants.
The verdict
NCT05356221 has completed, sponsored by Oticon Medical.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
Study Summary
The study is a non-interventional, observational, cross-sectional, study on users of Ponto sound processors. The purpose of this study is to evaluate subjectively assessed hearing performance and satisfaction with Oticon Medical's sound processors fitted with the Genie Medical fitting software.
Interventions
- DEVICE Ponto Sound processor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2024-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05356221
The ClinicalTrials.gov registry entry for NCT05356221 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oticon Medical, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ponto Sound processor is the first listed.
NCT05356221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05356221 about?
NCT05356221 is a clinical study titled "Cross-sectional Evaluation of the Subjective Performance and Satisfaction With Ponto Sound Processors". The study is a non-interventional, observational, cross-sectional, study on users of Ponto sound processors. The purpose of this study is to evaluate subjectively assessed hearing performance and satisfaction with Oticon Medical's sound processors fitted with the Genie Medical fitting software.
What is the current status of trial NCT05356221?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2022-04-11. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT05356221?
The interventions under investigation include: Ponto Sound processor (DEVICE).
Who is sponsoring clinical trial NCT05356221?
This trial is sponsored by Oticon Medical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.